Source - RNS
RNS Number : 4038R
Morgan Stanley Capital Services LLC
14 June 2018
 

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Shire plc

(d) Date dealing undertaken:

13 JUNE 2018

(e) Has the EPT previously disclosed, or is it today  disclosing, under the Code in respect of any other party to this offer?

Yes - Takeda Pharmaceutical Company Limited

 

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a)        Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total   number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 ADR

 PURCHASES

 1,345

 161.9100 USD

 161.3100 USD

 ADR

 SALES

 2,330

 161.7800 USD

 161.0500 USD

 

 

(b)        Cash-settled derivative transactions

 

 Class of relevant security

 Product description

            e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 ADR

 CFD

 LONG

 295

 161.3100 USD

 ADR

 CFD

 LONG

 296

 161.3100 USD

 ADR

 CFD

 LONG

 15

 161.3200 USD

 ADR

 CFD

 LONG

 397

 161.3412 USD

 ADR

 CFD

 LONG

 300

 161.3733 USD

 ADR

 CFD

 LONG

 415

 161.3922 USD

 ADR

 CFD

 LONG

 100

 161.4600 USD

 ADR

 CFD

 LONG

 47

 161.4600 USD

 ADR

 CFD

 LONG

 79

 161.4600 USD

 ADR

 CFD

 LONG

 351

 161.4600 USD

 ADR

 CFD

 LONG

 100

 161.7800 USD

 ADR

 CFD

 SHORT

 100

 161.3100 USD

 ADR

 CFD

 SHORT

 50

 161.3100 USD

 ADR

 CFD

 SHORT

 50

 161.3100 USD

 ADR

 CFD

 SHORT

 400

 161.3100 USD

 ADR

 CFD

 SHORT

 50

 161.3100 USD

 ADR

 CFD

 SHORT

 32

 161.3100 USD

 ADR

 CFD

 SHORT

 291

 161.3100 USD

 ADR

 CFD

 SHORT

 2

 161.4200 USD

 ADR

 CFD

 SHORT

 200

 161.5550 USD

 ADR

 CFD

 SHORT

 72

 161.6630 USD

 ADR

 CFD

 SHORT

 70

 161.6700 USD

 ADR

 CFD

 SHORT

 100

 161.9100 USD

 5p ordinary

 CFD

 LONG

 1,153

 40.2127 GBP

 5p ordinary

 CFD

 LONG

 216

 40.2181 GBP

 5p ordinary

 CFD

 LONG

 811

 40.2221 GBP

 5p ordinary

 CFD

 LONG

 49

 40.2320 GBP

 5p ordinary

 CFD

 LONG

 57

 40.3402 GBP

 5p ordinary

 CFD

 SHORT

 57

 40.2148 GBP

 5p ordinary

 CFD

 SHORT

 1,349

 40.2429 GBP

 5p ordinary

 CFD

 SHORT

 1,121

 40.2576 GBP

 5p ordinary

 CFD

 SHORT

 24

 40.2885 GBP

 5p ordinary

 CFD

 SHORT

 520

 40.3018 GBP

 5p ordinary

 CFD

 SHORT

 1,852

 40.3020 GBP

 

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description             e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type   e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii)        Exercise

 

 Class of relevant security

 Product description            e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d)        Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing            e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

14 JUNE 2018

Contact name:

Craig Horsley

Telephone number:

+44(141) 245 7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected].  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FERZMGMVLDKGRZG